Independent Grants for Learning & Change (IGLC): Track 2 - Call for Grant Applications (CGA) - Emerging Therapies in Inflammatory Bowel Disease (IBD)

Funding Agency:
Pfizer Inc.

The mission of Pfizer Independent Grants for Learning & Change (IGL&C) is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. “Independent” means that the projects funded by Pfizer are the full responsibility of the recipient organization. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly. Through this CGA we encourage organizations to submit grant requests that, if funded, will support education in a specific disease state, therapeutic area, or broader area of educational need. 

The intent of this CGA is to encourage organizations to design education programs to reach gastroenterologists’ and gastroenterology fellows’, nurse practitioners, physician assistants, and all other healthcare professionals involved in the care and treatment of adult patients with inflammatory bowel disease (IBD).

As research has progressed into the pathogenesis of the IBD spectrum, new therapeutic targets and strategies have been discovered.1 Programs aimed at increasing awareness and understanding of emerging therapies in the treatment of adult patients with IBD will be considered.

Programs with the highest likelihood of improving the health care team’s understanding of emerging therapies as well as a large reach in the treatment of inflammatory bowel disease will be given the highest priority.

Deadline: Feb. 24, 2017

Agency Website

Eligibility Requirements

The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. 

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.



Amount Description

Individual projects requesting up to $200,000 will be considered. The grant amount Pfizer will be prepared to fund will depend upon the evaluation of the proposal and costs involved and will be stated clearly in the approval notification

Funding Type





Curriculum Development
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 24, 2017